Skip to main content
. 2023 Dec 29;41(2):223–234. doi: 10.1007/s11095-023-03645-3

Table I.

Test Article Description and Dosing, BID (twice a day), QD (once a day)

Test Article Description Study # Application Rate Application Frequency
Brepocitinib 3% cream 1, 2 2.0 mg/cm2/dose BID, QD in Study#2
Brepocitinib 0.3% cream 1 2.0 mg/cm2/dose BID
Tofacitinib 2% ointment 1 3.0 mg/cm2/dose BID
Crisaborole 2% ointment 1 3.0 mg/cm2/dose BID
PF-06763809 2.3% solution 1, 2 2.5 µL/cm2/dose BID
PF-06263276 4% solution 1 2.5 µL/cm2/dose BID
Diclofenac Diethylamine 2% gel 1 2.5 mg/cm2/dose BID
Ruxolitinib 1.5% cream 2 2.0 mg/cm2/dose BID